Theregen Corp.

Theregen Corp.'s Anginera is a cell-based epicardial patch designed to promote blood vessel growth in ischemic cardiac tissue. Numerous animal studies have demonstrated that Anginera-which is based on the Dermagraft wound repair patch--promotes angiogenesis and arteriogenesis in ischemic tissue, and may also preserve or repair cardiac function in the failing heart.